Tim-3通过调控肺泡巨噬细胞极化与代谢重编程改善脓毒症急性肺损伤的作用机制

Action mechanisms of Tim-3 on improvement of patients with sepsis-induced acute lung injury by regulating alveolar macrophage polarization and metabolic reprogramming

  • 摘要: 目的 探讨T细胞免疫球蛋白及黏蛋白-3(Tim-3)在脓毒症急性肺损伤(ALI)患者中的表达特征及其对肺泡巨噬细胞极化、炎症反应和代谢重编程的调控作用。方法 选取2022年8月-2023年12月石河子大学第一附属医院收治的22例脓毒症ALI患者,依据肺泡灌洗液(BALF)中肺泡巨噬细胞Tim-3 mRNA表达水平,分为Tim-3高表达组(H-Tim3组,n=11)和Tim-3低表达组(L-Tim3组,n=11)。采用qRT-PCR检测肺泡巨噬细胞M1型极化标志物:诱导型一氧化氮合成酶(iNOS)、低亲和力免疫球蛋白γFc区域受体III-A(CD16A)、人趋化因子C-C-基元受体7(CCR7)、人类白细胞抗原-DRβ1(HLA-DRβ1)的mRNA表达; ELISA法检测BALF中Tim-3及炎症因子:肿瘤坏死因子-α(TNF-α)、转化生长因子-β1(TGF-β1)、白细胞介素(IL)-6、IL-10、IL-12水平; 流式细胞术分析M1/M2型巨噬细胞比例; 采用非靶向代谢组学分析BALF代谢物谱。结果 与L-Tim3组相比,H-Tim3组M1型极化标志物mRNA表达水平降低(P<0.05); 与L-Tim3组相比,H-Tim3组M1型(CD86+CD206-)比例降低11.51%,M2型(CD86-CD206+)比例升高6.38%,M1/M2比值降低50.00%(均P<0.001)。H-Tim3组BALF中Tim-3蛋白、TGF-β1及IL-10水平高于L-Tim3组(P<0.05); 代谢组学分析显示,H-Tim3组中二十二碳六烯酸、鞘氨醇等9种肺保护代谢物显著上调,其中以二十二碳六烯酸的相对含量差异最为显著,为L-Tim3组的40.54倍。结论 Tim-3高表达可能通过抑制M1型肺泡巨噬细胞极化、促进抑炎因子分泌及调控保护性代谢物表达,从而改善脓毒症ALI患者的肺功能; Tim-3具有作为预后生物标志物和潜在治疗靶点的价值。

     

    Abstract: OBJECTIVE To explore the expressions of T cell immunoglobulin and mucin domain-3 (Tim-3) in patients with sepsis-induced acute lung injury (ALI) and observed its effect on regulating the alveolar macrophage polarization, inflammatory response, and metabolic reprogramming. METHODS A total of 22 patients with sepsis-induced ALI who were treated in First Affiliated Hospital of Shihezi University from Aug. 2022 to Dec. 2023 were enrolled in the study and were divided into the Tim-3 high-expression group with 11 cases (the H-Tim3 group) and the Tim-3 low-expression group with 11 cases (the L-Tim3 group) according to the expression level of Tim-3 mRNA in alveolar macrophages from bronchoalveolar lavage fluid (BALF). The mRNA expressions of alveolar macrophage M1 polarization markers inducible nitric oxidesynthase (iNOS), low affinity immunoglobulin gamma Fc region receptor III-A (CD16A), C-C chemokine receptor type 7 (CCR7) and human leukocyte antigen-DRβ1 (HLA-DRβ1) were detected by qRT-PCR. The levels of Tim-3 and inflammatory factors in BALF: tumor necrosis factor-α(TNF-α), transforming growth factor-β1 (TGF-β1), interleukin (IL)-6, IL-10 and IL-12,were detected by means of ELISA. The ratio of M1 to M2 macrophage was analyzed by flow cytometry. The metabolite profiles of BALF were observed by untargeted metabolomics. RESULTS The mRNA expression levels of MI polarization markers of the H-Tim3 group were lower than those of the L-Tim3 group (P<0.05); as compared with the L-Tim3 group, the percentage of M1 (CD86+CD206-) of the H-Tim3 group decreased by 11.51%, the percentage of M2(CD86-CD206+) increased by 6.38%,and the ratio of M1 to M2 decreased by 50.00%( all P<0.001). The levels of Tim-3 protein, TGF-β1 and IL-10 in BALF were higher in the H-Tim3 group than in the L-Tim3 group (P<0.05). Metabonomics analysis showed that 9 types of lung-protective metabolites of the H-Tim3 group, including docosahexaenoic acid (DHA) and sphingosine, were upregulated remarkably, with the relative content of DHA differing most significantly, and it was as 40.54 times as much as that of the L-Tim3 group. CONCLUSIONS The high expression of Tim-3 may improve the lung function of the patients with sepsis-induced ALI by inhibiting M1 alveolar macrophage polarization, promoting the secretion of anti-inflammatory factors, and regulating the expression of protective metabolites. Tim-3 holds the value of being as a prognostic biomarker and a potential therapeutic target.

     

/

返回文章
返回